Skip to main content
. 2022 May 2;30(e1):e61–e65. doi: 10.1136/ejhpharm-2021-003100

Table 2.

General characteristics of patients included in the study and antibiotic prophylaxis

Antibiotic None n=20 Levofloxacin n=1 Ciprofloxacin n=5 Ciprofloxacin
+metronidazole n=1
Ciprofloxacin
+SMX/TMP n=23
Posology N/A 750 mg DIE (n=1) 750 mg BID (n=1)
500 mg BID (n=4)
750 mg BID
+500 mg TID (n=1)
500 mg BID+800/160 mg BID (n=18)
500 mg BID+800/160 mg DIE (n=3)
500 mg DIE +800/160 mg DIE (n=1)
500 mg BID+400/80 mg DIE (n=1)
Average duration (days) N/A 11 4.8 5 3.3
Patient characteristics (n=50)
 Male 17 0 2 1 12
 Female 3 1 3 0 11
 Age, median (years) 50 79 55 33 61
Leeches
 Quantity of leeches dispensed 60 169 78 75 59
 Average duration (days) 4.2 11 4.8 5 3.3

BID, twice a day; DIE, once a day; N/A, not applicable; SMX/TMP, sulfamethoxazole/trimethoprim; TID, three times a day.